Trial intelligence / Profile preview

Low-dose esketamine and lung function in gynecologic laparoscopic surgery

ChiCTR2100044310Phase 4Recruiting

Sponsor
Reproductive Hospital affiliated with Shandong University
Start
Mar 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of esketamine in Reduced lung compliance and Hypoxemia (2 arms), sponsored by Reproductive Hospital affiliated with Shandong University. Primary endpoints: Oxygenation index, Peak airway pressure and 1 more. Started Mar 2021; status: recruiting.

02

Drugs

esketamine
03

Conditions

Reduced lung complianceHypoxemia

Beyond the preview

Go deeper on ChiCTR2100044310.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100044310.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call